Ashleigh Hollowell

While LifeStance (Nasdaq: LFST) is no longer pursuing large platform consolidation, small tuck-in acquisitions and new market expansions are on the table.

Private investment firm Atar Capital is reportedly in the process of selling Clarvida, a behavioral health company that provides outpatient and telehealth care to underserved populations across 17 states.

This is an exclusive BHB+ story. ​Behavioral health providers are still fighting to reach many of the milestones and developments that physical health providers have achieved.

This is an exclusive BHB+ story. Behavioral health expansion is often driven by markets with favorable reimbursement rates.

Dealmaking in autism and intellectual and developmental disabilities (IDD) services looks different in 2026, shaped by an uptick in demand and heightened federal scrutiny. Buyers, both on the provider side and from investment firms, are adjusting their playbooks accordingly.

Drug overdose deaths fell for a third consecutive year in 2025, down by . It's the first time the fatal overdoses have dipped to pre-pandemic levels, according to data from the Centers for Disease Control and Prevention.

Stasia Huiner, chief operating officer of Mindpath Health, has taken the reins as the company's new CEO and will also join the company's board of directors effective immediately.

This is an exclusive BHB+ story. Serial behavioral health buyers, including LifeStance Health (Nasdaq: LFST), ARC Health and Beacon Behavioral

This is a BHB+ story. Amid rising rate pressures, some small-scale, independent therapists feel pressured by payers to relinquish their independent

MDMA-assisted therapy is the focus of a new clinical trial led by the Department of Veterans Affairs. It will enroll 80 veterans who experience